BR112018001313A2 - composição de zolpidem e processo para preparar a mesma - Google Patents
composição de zolpidem e processo para preparar a mesmaInfo
- Publication number
- BR112018001313A2 BR112018001313A2 BR112018001313A BR112018001313A BR112018001313A2 BR 112018001313 A2 BR112018001313 A2 BR 112018001313A2 BR 112018001313 A BR112018001313 A BR 112018001313A BR 112018001313 A BR112018001313 A BR 112018001313A BR 112018001313 A2 BR112018001313 A2 BR 112018001313A2
- Authority
- BR
- Brazil
- Prior art keywords
- preparing
- zolpidem composition
- zolpidem
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Physiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Organic Chemistry (AREA)
- Anesthesiology (AREA)
- Zoology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN2793/MUM/2015 | 2015-07-23 | ||
IN2793MU2015 | 2015-07-23 | ||
PCT/IN2016/050211 WO2017013678A1 (en) | 2015-07-23 | 2016-06-30 | Zolpidem composition and process for preparing the same |
Publications (2)
Publication Number | Publication Date |
---|---|
BR112018001313A2 true BR112018001313A2 (pt) | 2018-09-11 |
BR112018001313B1 BR112018001313B1 (pt) | 2023-05-02 |
Family
ID=57834133
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112018001313-7A BR112018001313B1 (pt) | 2015-07-23 | 2016-06-30 | Composição de zolpidem e processo para preparar a mesma |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP3324971A1 (pt) |
CN (1) | CN107921045B (pt) |
BR (1) | BR112018001313B1 (pt) |
CA (1) | CA2993597A1 (pt) |
MX (1) | MX2018000939A (pt) |
RU (1) | RU2690159C1 (pt) |
WO (1) | WO2017013678A1 (pt) |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2772615B1 (fr) * | 1997-12-23 | 2002-06-14 | Lipha | Comprime multicouche pour la liberation instantanee puis prolongee de substances actives |
US20070292498A1 (en) * | 2003-11-05 | 2007-12-20 | Warren Hall | Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers |
WO2005065640A1 (en) * | 2004-01-06 | 2005-07-21 | Panacea Biotec Ltd. | Compositions of buccal dosage forms for extended drug release and the process of preparing such compositions |
ZA200606411B (en) * | 2004-02-17 | 2008-05-28 | Transoral Pharmaceuticals Inc | Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof |
KR20150038745A (ko) * | 2004-02-17 | 2015-04-08 | 트랜스셉트 파마슈티칼스, 인코포레이티드 | 구강 점막을 가로지르는 수면제 전달용 조성물 및 이의 사용 방법 |
US20070098788A1 (en) * | 2005-10-28 | 2007-05-03 | Gore Subhash P | Non-benzodiazepine hypnotic compositions |
US20070259040A1 (en) * | 2006-05-01 | 2007-11-08 | Cherukuri S R | Novel triptan formulations and methods for making them |
US20080132535A1 (en) * | 2006-11-30 | 2008-06-05 | Transcept Pharmaceuticals, Inc. | Stabilized Zolpidem Pharmaceutical Compositions |
US20130078304A1 (en) * | 2011-09-28 | 2013-03-28 | Taiwan Biotech Co., Ltd. | Controlled release formulation for treating sleep disorders |
US20130143912A1 (en) * | 2011-12-06 | 2013-06-06 | Dr. Reddy's Laboratories Inc. | Sublingual zolpidem formulations |
CN102860997A (zh) * | 2012-09-28 | 2013-01-09 | 天津市聚星康华医药科技有限公司 | 一种遮味的昂丹司琼口腔速溶膜及其制备方法 |
-
2016
- 2016-06-30 WO PCT/IN2016/050211 patent/WO2017013678A1/en active Application Filing
- 2016-06-30 RU RU2018106131A patent/RU2690159C1/ru active
- 2016-06-30 CN CN201680043388.0A patent/CN107921045B/zh active Active
- 2016-06-30 MX MX2018000939A patent/MX2018000939A/es unknown
- 2016-06-30 BR BR112018001313-7A patent/BR112018001313B1/pt active IP Right Grant
- 2016-06-30 EP EP16827382.9A patent/EP3324971A1/en active Pending
- 2016-06-30 CA CA2993597A patent/CA2993597A1/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP3324971A4 (en) | 2018-05-30 |
CN107921045B (zh) | 2021-03-09 |
CN107921045A (zh) | 2018-04-17 |
EP3324971A1 (en) | 2018-05-30 |
CA2993597A1 (en) | 2017-01-26 |
BR112018001313B1 (pt) | 2023-05-02 |
MX2018000939A (es) | 2018-06-07 |
WO2017013678A1 (en) | 2017-01-26 |
RU2690159C1 (ru) | 2019-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3359095T3 (da) | Automatiseret hånd | |
BR112016022458A2 (pt) | formulação de poliuretano, método para rodução de um material de poliuretano, e, material de poliuretano | |
DK3242884T3 (da) | Kationiske neurotoksiner | |
DK3341479T3 (da) | LNA-G-Proces | |
DK3170627T3 (da) | Redskab | |
BR112016025076A2 (pt) | processo para a preparação de ciclosserinas substituídas | |
BR112016030604A2 (pt) | Processo para preparação de ácidos 3- hidroxipicolínicos | |
CL2015002384S1 (es) | Maquina para preparar bebidas | |
BR112017007069A2 (pt) | composição sinérgica para osteoartrite | |
BR112016027819A2 (pt) | Processo de preparação de derivados de tiazole | |
BR112016019843A2 (pt) | processo de biorrefinamento | |
MA44385A (fr) | Pince | |
DK3285558T3 (da) | Græslægningsmaskine | |
FI20156045A (fi) | Kationinen pintaliima-aine | |
GB201518570D0 (en) | Blade positioning | |
BR112017008394A2 (pt) | aparelho e método para dobrar | |
FI20155486A (fi) | Karsintaterä | |
DE102014224930A8 (de) | Fugeneinkehrmaschine | |
BR112018001313A2 (pt) | composição de zolpidem e processo para preparar a mesma | |
ITUB20153989A1 (it) | Marcatrice | |
ES1135628Y (es) | Monoboya para vertido controlado | |
ES1189683Y (es) | Maquina para fabricar pales | |
ES1183259Y (es) | Maquina para despelonado de nueces | |
ES1166158Y (es) | Tapa-colador para ollas exprés | |
BR112017007508A2 (pt) | processo para preparação de trifluoroacetofenonas substituídas por halo |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B25A | Requested transfer of rights approved |
Owner name: ATHENA PHARMACEUTIQUES SAS (FR) |
|
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 30/06/2016, OBSERVADAS AS CONDICOES LEGAIS |